A Calculated Move: Putting Environmental Assessment Data To Wider Use
By Cristin Konkart and Shawn James

Environmental assessment is becoming more than a way to calculate and report a product’s carbon footprint. As pharmaceutical and medical device companies face growing demands for reliable sustainability data, Product Carbon Footprint (PCF) assessments and Life Cycle Assessments (LCAs) can help inform decisions much earlier in product development.
Robust assessments depend on more than a final emissions figure. Supplier-specific data, transparent methodologies, current environmental databases, production conditions, material expertise, and clearly defined assumptions all shape the reliability of the results. Cross-functional input from procurement, manufacturing, sustainability, materials, packaging, and logistics adds further context.
When this expertise is brought upstream, environmental data can help teams compare materials, suppliers, production locations, reuse models, and end-of-life scenarios before designs are finalized. See how PCF and LCA methodologies are evolving from measurement tools into practical resources for identifying trade-offs and finding opportunities to reduce environmental impact.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.